Jump to main content
Jump to site search

Issue 11, 2012
Previous Article Next Article

Synthesis of tetrazole–isoxazoline hybrids as a new class of tubulin polymerization inhibitors

Author affiliations

Abstract

A new series of tetrazole based isoxazolines (4a–l) was synthesized and evaluated for their anticancer potential against two cancer cell lines. All these compounds exhibited profound cytotoxicity with IC50 values ranging from 1.22 to 3.62 μM and compounds 4h, 4i showed prominent anticancer efficacy with IC50 values of 1.51, 1.49 μM in A549 and 2.83, 2.40 μM in MDA-MB-231 cell lines. Further, these compounds (4h, 4i) induced apoptotic cell death by inhibition of tubulin polymerization leading to cell cycle arrest at G2/M phase of the cell cycle followed by caspase-3 activity. Moreover, the level of tubulin inhibition by these compounds was examined by in vitro HTS tubulin polymerization assay. Docking of compound 4h and 4i to the active site of tubulin revealed that the trimethoxy ring of the compounds occupies the colchicine binding site of tubulin, whereas the isoxazoline moiety moves towards the interface of α–β tubulin and involves a series of hydrogen bonds with αTyr224 and αSer178.

Graphical abstract: Synthesis of tetrazole–isoxazoline hybrids as a new class of tubulin polymerization inhibitors

Back to tab navigation

Supplementary files

Publication details

The article was received on 04 Apr 2012, accepted on 18 May 2012 and first published on 25 May 2012


Article type: Concise Article
DOI: 10.1039/C2MD20085F
Med. Chem. Commun., 2012,3, 1386-1392

  •   Request permissions

    Synthesis of tetrazoleisoxazoline hybrids as a new class of tubulin polymerization inhibitors

    A. Kamal, A. Viswanath, M. J. Ramaiah, J. N. S. R. C. Murty, F. Sultana, G. Ramakrishna, J. R. Tamboli, S. N. C. V. L. Pushpavalli, D. pal, C. Kishor, A. Addlagatta and M. P. Bhadra, Med. Chem. Commun., 2012, 3, 1386
    DOI: 10.1039/C2MD20085F

Search articles by author

Spotlight

Advertisements